Search results
Results From The WOW.Com Content Network
Vivek Ganapathy Ramaswamy [a] (born August 9, 1985) is an American entrepreneur and politician. He founded Roivant Sciences , a pharmaceutical company , in 2014. In February 2023, Ramaswamy declared his candidacy for the Republican Party nomination in the 2024 United States presidential election .
Vivek Ramaswamy founded Roivant in 2014. [4] Ramaswamy's initial strategy was to in-license drug candidates and create subsidiaries focused on distinct therapeutic areas. [ 5 ] This strategy expanded to include developing earlier stage drug candidates and platform technologies.
Also Read: Vivek Ramaswamy-Founded Roivant’s Anti-Inflammatory Drug Aces Mid-Stage Study. As previously disclosed, the batoclimab phase 2a trial in uncontrolled Graves’ Disease enrolled p.
Vivek Ramaswamy, then a politically active biology major, led the dissent. Writing for the school newspaper, he argued that a raise would come “at the cost of respect that the rest of the ...
In November, the president-elect announced that Musk (along with entrepreneur Vivek Ramaswamy) would lead a new “Department of Government Efficiency” tasked with “provid[ing] advice and ...
The company was founded by former hedge fund analyst and 2024 Republican Party presidential primary candidate Vivek Ramaswamy [1] in October 2014 as a wholly owned subsidiary of Roivant Sciences, which was itself founded in May 2014. [2]
The beliefs that powered a revolution 248 years ago are the vision our nation needs now, Vivek Ramaswamy writes to Iowa caucusgoers. Vivek Ramaswamy: We are in a 1776 moment, and I have a vision ...
Wealthy millennial entrepreneur Vivek Ramaswamy was the target of a barrage of attacks during Wednesday's first GOP presidential debate for the 2024 Republican nomination.